Published in Stem Cell Week, March 14th, 2005
This is the company's first set of patent applications. A spokesperson for Bio-Matrix said the management team is enthusiastic about the progress being made by the company over a short period of time.
"I'm excited about this first patent application, it represents the company coming of age. As the person coordinating our Research and Development, I believe this first patent should be one of many more to come. The company's goal is to be recognized as a key player in stem cell and medical device technologies," said Phil Watts,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Stem Cell Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.